Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Works of J.L. Lee being referenced
KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)
2018
Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J.L. Lee | 173 | 288 | 60 | 135 | 14 | 459 | |
| Sandeep Reddy | 92 | 215 | 43 | 154 | 18 | 439 | |
| Yan-Xia Shi | 143 | 347 | 106 | 59 | 19 | 534 | |
| Monica Rizzo | 204 | 194 | 100 | 59 | 20 | 475 | |
| H. S. Hochster | 126 | 421 | 41 | 75 | 21 | 507 | |
| T. Megha | 66 | 212 | 57 | 156 | 16 | 496 | |
| Jory G. Magidson | 85 | 201 | 113 | 140 | 16 | 477 | |
| Pamela A. Althof | 175 | 196 | 113 | 85 | 16 | 462 | |
| Vincenzo Rosario Iaffaioli | 76 | 310 | 105 | 133 | 25 | 511 | |
| C. von Schilling | 90 | 176 | 78 | 97 | 21 | 493 | |
| Smitha Menon | 125 | 293 | 28 | 134 | 17 | 457 |
All Works
Login with ORCID to disown or claim papers
Loading papers...